Vanguard Global Advisers’s Olema Oncology OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$246K Buy
28,455
+9,389
+49% +$102K ﹤0.01% 2393
2026
Q2
$239K Sell
19,066
-21,665
-53% -$290K ﹤0.01% 2434
2026
Q1
$607K Buy
+40,731
New +$907K ﹤0.01% 1943

Other funds holding OLMA

Vanguard Global Advisers's OLMA Position: Q3 2026 in Review

Vanguard Global Advisers increased its Olema Oncology (OLMA) stake by 49% in Q3 2026, buying an estimated $102K and bringing the position to 28,455 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #2393.

Vanguard Global Advisers first reported a position in OLMA in Q1 2026 and has held it in 3 quarters since. The position peaked at $607K in Q1 2026. 179 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Vanguard Global Advisers held 28,455 shares of Olema Oncology worth $246K as of Q3 2026.
  • Vanguard Global Advisers bought 9,389 Olema Oncology shares in Q3 2026, an estimated $102K.
  • Olema Oncology made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2393 holding.
  • Vanguard Global Advisers first reported a position in Olema Oncology in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Olema Oncology position peaked at $607K in Q1 2026.
  • 179 funds tracked by Wall St. Rank held Olema Oncology as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.